Franklin Street Advisors Inc. NC Cuts Position in The Procter & Gamble Company (NYSE:PG)

Franklin Street Advisors Inc. NC lessened its stake in The Procter & Gamble Company (NYSE:PGGet Rating) by 1.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 63,976 shares of the company’s stock after selling 665 shares during the quarter. Franklin Street Advisors Inc. NC’s holdings in Procter & Gamble were worth $9,513,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Capital Investment Advisory Services LLC grew its stake in Procter & Gamble by 4.9% in the 4th quarter. Capital Investment Advisory Services LLC now owns 36,681 shares of the company’s stock valued at $5,559,000 after acquiring an additional 1,711 shares during the last quarter. Deuterium Capital Management LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter worth about $675,000. CX Institutional boosted its stake in shares of Procter & Gamble by 4.1% during the 4th quarter. CX Institutional now owns 33,743 shares of the company’s stock worth $5,114,000 after purchasing an additional 1,320 shares during the last quarter. Oak Harbor Wealth Partners LLC boosted its stake in shares of Procter & Gamble by 11.1% during the 4th quarter. Oak Harbor Wealth Partners LLC now owns 30,891 shares of the company’s stock worth $4,682,000 after purchasing an additional 3,089 shares during the last quarter. Finally, Blue Chip Partners LLC boosted its stake in shares of Procter & Gamble by 1.9% during the 4th quarter. Blue Chip Partners LLC now owns 21,503 shares of the company’s stock worth $3,259,000 after purchasing an additional 409 shares during the last quarter. Hedge funds and other institutional investors own 64.65% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG opened at $149.95 on Friday. The Procter & Gamble Company has a 1 year low of $122.18 and a 1 year high of $158.11. The company has a market cap of $353.43 billion, a price-to-earnings ratio of 26.12, a price-to-earnings-growth ratio of 4.16 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.39 and a current ratio of 0.59. The firm has a fifty day moving average of $150.68 and a 200-day moving average of $147.42.

Procter & Gamble (NYSE:PGGet Rating) last announced its quarterly earnings results on Friday, April 21st. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.32 by $0.05. Procter & Gamble had a net margin of 17.69% and a return on equity of 32.18%. The company had revenue of $20.07 billion during the quarter, compared to the consensus estimate of $19.32 billion. During the same quarter in the previous year, the company posted $1.33 earnings per share. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. As a group, equities analysts anticipate that The Procter & Gamble Company will post 5.86 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, May 15th. Investors of record on Friday, April 21st were paid a dividend of $0.9407 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.91. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date was Thursday, April 20th. Procter & Gamble’s payout ratio is currently 65.51%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 4,852 shares of the business’s stock in a transaction dated Wednesday, April 26th. The shares were sold at an average price of $155.47, for a total value of $754,340.44. Following the sale, the insider now directly owns 7,977 shares in the company, valued at $1,240,184.19. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,000 shares of the business’s stock in a transaction dated Monday, May 1st. The stock was sold at an average price of $156.03, for a total transaction of $4,836,930.00. Following the sale, the chief operating officer now owns 10,014 shares in the company, valued at approximately $1,562,484.42. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Susan Street Whaley sold 4,852 shares of the business’s stock in a transaction dated Wednesday, April 26th. The stock was sold at an average price of $155.47, for a total value of $754,340.44. Following the sale, the insider now owns 7,977 shares in the company, valued at approximately $1,240,184.19. The disclosure for this sale can be found here. Insiders have sold a total of 95,093 shares of company stock worth $14,821,930 over the last ninety days. 0.26% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on PG. Barclays raised their price target on shares of Procter & Gamble from $160.00 to $167.00 in a research note on Wednesday, April 26th. Raymond James raised their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Sunday, April 23rd. Deutsche Bank Aktiengesellschaft raised their target price on shares of Procter & Gamble from $160.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, April 24th. Evercore ISI raised their target price on shares of Procter & Gamble from $160.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, April 24th. Finally, Truist Financial cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and decreased their target price for the stock from $165.00 to $155.00 in a research report on Thursday, May 18th. Five investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $161.50.

Procter & Gamble Company Profile

(Get Rating)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGGet Rating).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.